Alkeon Capital Management Reduces $7M in Hinge Health, Inc. ($HNGE)
Key Points
- Alkeon Capital Management changed its Hinge Health, Inc. ($HNGE) stake by 12.6% last quarter, cutting to 691,104 shares worth $45.11 million.
- Wall Street's consensus rating on $HNGE is Buy and an average price target of $76.80.
- $HNGE last traded around $65.27.
Alkeon Capital Management reduced its position in Hinge Health, Inc. ($HNGE) by 12.6% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 691,104 shares of Hinge Health, Inc. after selling 100,000 shares during the quarter. Alkeon Capital Management's holdings in Hinge Health, Inc. were worth $45.11 million as of its most recent filing.
Hinge Health, Inc. ($HNGE) Stock
Hinge Health, Inc. Earnings
Analysts Set New Price Targets
About Hinge Health, Inc.
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.
See Also
This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.